AC Immune ACIU
NASDAQ ACIU
$2.49 +0.06 (+2.26%)
At close: Oct 20, 2026 · 4:00 PM EDT

AC Immune (ACIU) Total Current Liabilities (2014 - 2026)

Updated

AC Immune (ACIU) reported Total Current Liabilities of $126.83 million for the quarter ended Jun 30, 2026, up 6.1% from $119.54 million a year earlier and up 7.7% from the prior quarter.

Analysis

AC Immune (ACIU) Total Current Liabilities (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, AC Immune posted Total Current Liabilities of $114.21 million, down 0.4% from the prior year.

  • Total Current Liabilities has a five-year compound annual growth rate of 50.2% (years ended Dec 2020 to Dec 2025).
  • By year, Total Current Liabilities came in at $114.62 million in the year ended Dec 31, 2024 (+658.3%), $15.12 million in the year ended Dec 31, 2023 (+25.6%), $12.04 million in the year ended Dec 31, 2022 (-45.1%) and $21.92 million in the year ended Dec 31, 2021 (+46.6%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Total Current Liabilities in data going back to the quarter ended Dec 31, 2014.
  • Year over year, Total Current Liabilities has now increased in each of the last 11 quarters, with growth averaging 255.3% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was the quarter ended Jun 30, 2024 (growth of 796.2%); the low point was the quarter ended Dec 31, 2022 (a decline of 45.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $117.8 million (quarter ended Mar 31, 2026), $118.48 million (quarter ended Dec 31, 2025) and $122.87 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 54.90 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 41.64 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.02 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 32.65 Bn
10 AC Immune 250.37 Mn -188.03 Mn - 124.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.12 Mn
Mar 31, 2026 115.33 Mn
Dec 31, 2025 119.61 Mn
Sep 30, 2025 123.29 Mn
Jun 30, 2025 123.98 Mn
Mar 31, 2025 112.67 Mn
Dec 31, 2024 111.64 Mn
Sep 30, 2024 120.15 Mn
Jun 30, 2024 111.88 Mn
Mar 31, 2024 15.67 Mn
Dec 31, 2023 16.10 Mn
Sep 30, 2023 12.80 Mn
Jun 30, 2023 12.40 Mn
Mar 31, 2023 11.77 Mn
Dec 31, 2022 12.44 Mn
Sep 30, 2022 13.95 Mn
Jun 30, 2022 12.50 Mn
Mar 31, 2022 12.91 Mn
Dec 31, 2021 21.92 Mn
Sep 30, 2021 15.22 Mn
API Access

AC Immune Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ACIU&period=max&api_key=YOUR_API_KEY